Robert Rosen is President at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have made 7 open-market trades across 1 company since 2016, most recently 2018-07-02.
CIK 0000818033
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HRTX | 2,640 | $968 |
Shares reported on the most recent Form 4, priced at the 2018-07-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRTX | SELL | 2018-06-29 | 2018-07-03 | $38.98 | $17.4M | -1.9% | -7.1% | -21.1% |
| HRTX | SELL | 2016-08-10 | 2016-08-12 | $23.29 | $2.3M | -3.4% | -5.6% | -10.2% |
| HRTX | SELL | 2016-08-10 | 2016-08-12 | $23.30 | $2.3M | -3.4% | -5.6% | -10.2% |
| HRTX | SELL | 2016-04-21 | 2016-04-21 | $22.15 | $436K | -0.2% | -11.8% | -25.3% |
| HRTX | SELL | 2016-04-20 | 2016-04-21 | $22.19 | $89K | -0.2% | -11.8% | -25.3% |
| HRTX | SELL | 2016-04-19 | 2016-04-21 | $23.38 | $4.1M | -0.2% | -11.8% | -25.3% |
| HRTX | SELL | 2016-04-19 | 2016-04-21 | $23.23 | $9.3M | -0.2% | -11.8% | -25.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.